SCHEMBL12424111

SCHEMBL12424111

CC(F)(F)c1ccccc1-c1onc(-c2ccc(Cl)cc2)c1C(O)c1cccnc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KCNA5 P22460 4/20 0.35
ATM Q13315 2/20 0.35
KMT2A Q03164 1/20 0.35
CYP19A1 P11511 1/20 0.34
GAA P10253 1/20 0.34
CYP17A1 P05093 1/20 0.34
CYP3A4 P08684 2/20 0.34
PDE10A Q9Y233 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34
BRD4 O60885 1/20 0.33
KCND3 Q9UK17 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199880 0.92 CYP3A4 (0.39) SMN1; SMN2LMNAL3MBTL1KCNA5ATM
SCHEMBL2198716 0.85 KCNA5 (0.44) SMN1; SMN2LMNAL3MBTL1KCNA5ATM
SCHEMBL2201559 0.83 POLB (0.42) SMN1; SMN2LMNAL3MBTL1ATMKMT2A
SCHEMBL2199854 0.82 CYP19A1 (0.44) SMN1; SMN2LMNAL3MBTL1KCNA5ATM
SCHEMBL2197322 0.82 KCNA5 (0.37) SMN1; SMN2KCNA5ATMCYP17A1CYP3A4
SCHEMBL2197190 0.82 SMN1; SMN2 (0.47) SMN1; SMN2LMNAL3MBTL1KCNA5ATM
SCHEMBL3115056 0.81 CYP3A4 (0.43) SMN1; SMN2KCNA5KMT2ACYP19A1CYP17A1
SCHEMBL2198960 0.80 CYP11B1 (0.39) SMN1; SMN2L3MBTL1KCNA5CYP17A1CYP3A4
SCHEMBL2198005 0.80 HSD11B1 (0.40) SMN1; SMN2LMNAL3MBTL1KCNA5ATM
SCHEMBL12211657 0.80 SMN1; SMN2 (0.36) SMN1; SMN2LMNAL3MBTL1KCNA5CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096843-A1 Substituted Isoxazoles as Fungicides CYP4X1, CYP51A1, CYP3A7 SMN1; SMN2 2387/4885LMNA 3361/4885L3MBTL1 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.